The direction of travel to better outcomes for patients with oesophago-gastric cancer.
作者信息
Langley Ruth Elizabeth
机构信息
MRC Clinical Trials Unit at University College London, London, UK.
出版信息
J Thorac Dis. 2018 Mar;10(3):1236-1238. doi: 10.21037/jtd.2018.03.23.
Abstract
摘要
相似文献
1
The direction of travel to better outcomes for patients with oesophago-gastric cancer.改善食管癌和胃癌患者治疗效果的发展方向。
J Thorac Dis. 2018 Mar;10(3):1236-1238. doi: 10.21037/jtd.2018.03.23.
2
Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer.肌肉减少症与接受食管癌和胃癌新辅助化疗患者的毒性反应相关。
Eur J Surg Oncol. 2015 Mar;41(3):333-8. doi: 10.1016/j.ejso.2014.11.040. Epub 2014 Nov 26.
3
EndoFLIP system for the intraoperative evaluation of peroral endoscopic myotomy.经口内镜下肌切开术的术中评估的 EndoFLIP 系统。
United European Gastroenterol J. 2014 Apr;2(2):77-83. doi: 10.1177/2050640614521193.
4
Main influencing factors and health-related quality of life issues in patients with oesophago-gastric cancer - as measured by EORTC tools.采用欧洲癌症研究与治疗组织（EORTC）工具测量的食管癌和胃癌患者的主要影响因素及与健康相关的生活质量问题
Contemp Oncol (Pozn). 2013;17(3):311-6. doi: 10.5114/wo.2013.35280. Epub 2013 Jun 28.
5
Gangrene of the oesophago-gastric junction caused by strangulated hiatal hernia: operative challenge or surgical dead end.食管胃交界部绞窄性食管裂孔疝导致的坏疽：手术挑战还是手术死胡同。
Ir J Med Sci. 2014 Jun;183(2):323-30. doi: 10.1007/s11845-013-0981-3. Epub 2013 Jun 28.
6
The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction.食管胃交界腺癌的复发模式。
Br J Cancer. 2002 Apr 22;86(8):1223-9. doi: 10.1038/sj.bjc.6600252.
7
MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients.微小RNA作为HER2阳性晚期食管胃癌患者基于曲妥珠单抗治疗的生物标志物
Front Oncol. 2023 Nov 29;13:1258365. doi: 10.3389/fonc.2023.1258365. eCollection 2023.
8
Psychosocial functioning in individuals with advanced oesophago-gastric cancer: a mixed methods systematic review.晚期胃食管癌症患者的社会心理功能：混合方法系统评价。
BMC Palliat Care. 2023 Oct 28;22(1):164. doi: 10.1186/s12904-023-01288-0.
9
Modified Oesophago-Gastric Dissociation (M-OGD) - a technical modification.改良的食管-胃分离术（M-OGD）——一种技术改良。
Updates Surg. 2021 Apr;73(2):775-778. doi: 10.1007/s13304-020-00934-z. Epub 2020 Dec 3.
10
Assessing quality of care in oesophago-gastric cancer surgery in Australia.评估澳大利亚食管癌和胃癌手术的护理质量。
ANZ J Surg. 2018 Apr;88(4):290-295. doi: 10.1111/ans.13752. Epub 2016 Sep 6.
本文引用的文献
1
Tumor Mutational Burden and Response Rate to PD-1 Inhibition.肿瘤突变负荷与对PD-1抑制的反应率
N Engl J Med. 2017 Dec 21;377(25):2500-2501. doi: 10.1056/NEJMc1713444.
2
Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.胃食管交界部癌系统治疗反应的遗传学预测因子。
Cancer Discov. 2018 Jan;8(1):49-58. doi: 10.1158/2159-8290.CD-17-0787. Epub 2017 Nov 9.
3
Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform.将生物标志物分层纳入STAMPEDE：一个适应性多臂、多阶段试验平台。
Clin Oncol (R Coll Radiol). 2017 Dec;29(12):778-786. doi: 10.1016/j.clon.2017.10.004. Epub 2017 Oct 25.
4
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial.纳武利尤单抗治疗既往至少两种化疗方案治疗失败或不耐受的晚期胃或胃食管结合部腺癌患者（ONO-4538-12，ATTRACTION-2）：一项随机、双盲、安慰剂对照、III 期临床试验。
Lancet. 2017 Dec 2;390(10111):2461-2471. doi: 10.1016/S0140-6736(17)31827-5. Epub 2017 Oct 6.
5
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.基因组异质性是胃食管腺癌精准医疗的障碍。
Cancer Discov. 2018 Jan;8(1):37-48. doi: 10.1158/2159-8290.CD-17-0395. Epub 2017 Oct 4.
6
Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients.亚洲和西方患者胃腺癌中的体细胞拷贝数改变
PLoS One. 2017 Apr 20;12(4):e0176045. doi: 10.1371/journal.pone.0176045. eCollection 2017.
7
Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial.错配修复缺陷、微卫星不稳定与生存：英国医学研究理事会辅助胃输注化疗（MAGIC）试验的探索性分析
JAMA Oncol. 2017 Sep 1;3(9):1197-1203. doi: 10.1001/jamaoncol.2016.6762.
8
Integrated genomic characterization of oesophageal carcinoma.食管癌的综合基因组特征分析
Nature. 2017 Jan 12;541(7636):169-175. doi: 10.1038/nature20805. Epub 2017 Jan 4.
9
The evolving role of microsatellite instability in colorectal cancer: A review.微卫星不稳定性在结直肠癌中的演变作用：综述。
Cancer Treat Rev. 2016 Dec;51:19-26. doi: 10.1016/j.ctrv.2016.10.005. Epub 2016 Oct 27.
10
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.食管腺癌中的突变特征定义了具有治疗相关性的病因学上不同的亚组。
Nat Genet. 2016 Oct;48(10):1131-41. doi: 10.1038/ng.3659. Epub 2016 Sep 5.
Zotero 插件